Taipei Municipal Wanfang Hospital

  • No. 111, Section 3, Xing-Long Road

    11696 Taipei

Organization profile

Organisation profile

Taipei Municipal Wan Fang Hospital, as a private management of public hospital, has been operating by Taipei Medical University since 1997.

Wan Fang Hospital lays emphasis on high quality medical service comprehensively; moreover, it has obtained the certification of Medical center level in 7 years and has received many awards since operated. Honorably, Wan Fang Hospital becomes the first hospital to get the accreditation of JCI for four times in 2015. That’s proved quality of service is our pride again.

From the beginning, our hospital visions were, to treat patients with respect, become a center of integrative medicine and provide comprehensive care for all and provide community-oriented service. As an internationally renowned university hospital, Wan Fang Hospital is totally dedicated to provide highest quality of care to our patients.

Fingerprint Dive into the research topics where Taipei Municipal Wanfang Hospital is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects

    牙齒長照整合技術暨服務產業平台之產學聯盟(1/3)

    Chou, H.

    2/1/201/31/21

    Project: A - Government Institutionb - Ministry of Science and Technology

    為何台灣自殺率上升而南韓自殺率下降?台灣與南韓自殺率的時間趨勢分析(1/2)

    Hsu, C.

    2/1/201/31/21

    Project: A - Government Institutionb - Ministry of Science and Technology

    新聘教師研究補助

    Lin, Y.

    1/1/2012/31/20

    Project: B - Project of TMUg - Research Grants for Newly Hired Faculty

    Research Output

    Activation of PERK contributes to apoptosis and G2/M arrest by microtubule disruptors in human colorectal carcinoma cells

    Wu, M. S., Chien, C. C., Jargalsaikhan, G., Ilsan, N. A. & Chen, Y. C., Jan 2020, In : Cancers. 12, 1, 97.

    Research output: Contribution to journalArticle

    Open Access
  • A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(αK): A phase II study

    Pan, S. C., Hsu, W. T., Lee, W. S., Wang, N. C., Chen, T. J., Liu, M. C., Pai, H. C., Hsu, Y. S., Chang, M. & Hsieh, S. M., Jan 29 2020, In : Vaccine. 38, 5, p. 1048-1056 9 p.

    Research output: Contribution to journalArticle

  • Open Access